Patheon

Sustainable #APIdevelopment at Thermo Fisher Scientific means going "greener by design." To do so, we’re transitioning to resource-efficient processes, integrating green chemistry practices, and prioritizing circular economy principles to achieve net-zero emissions by 2050. Watch our video from #CPHINorthAmerica featuring Matt Hancock learn more about our company’s approach to #sustainability in #drugdevelopment. As a leading #CDMO, we’re doing our part to create a more eco-friendly future for the #pharmaceutical industry. Watch the full video here: http://spr.ly/6045cONuU

#Predictivemodeling via #computationalsimulation has the potential to fundamentally change the complex #drugresearch and development process. Our blog takes a look at specific advantages of predictive modeling, breaking down these four benefits for solubility and bioavailability enhancement: - Efficient formulation optimization - Early identification of potential issues - Cost and time savings - Insights into mechanisms and interactions Additionally, it showcases Thermo Fisher Scientific's Quadrant 2™ predictive platform, which can streamline decision-making for pharmaceutical formulators. You can read the full blog here: http://spr.ly/6041igzEd

Mastering #technologytransfers is a crucial step to ensure successful #drugproduct market introduction and commercialization. Our comprehensive guide, "9 ways to ensure a successful technology transfer," provides detailed insights into achieving efficient, reliable, and seamless transitions from late-phase to commercial drug manufacturing. Discover how leveraging an integrated network, proactive planning and risk management, and Thermo Fisher Scientific’s #CDMO expertise can streamline the market introduction of your #pharmaceutical. To get the guide, click here: http://spr.ly/6043iLcux

Fostering a culture of #knowledgeharing is foundational at Thermo Fisher Scientific, where the open exchange of insights across departments fuels our success as a #CDMO. In our latest #voicesofpartnership video, Emily Anderson and Jessica Floyd reflect on their experiences working in our analytical #researchanddevelopment department. Specifically, they highlight how shared #knowledge and cross-team #collaboration enhance operational flexibility, ensuring vital information reaches clients more quickly. Watch the video to see how our commitment to #knowledgesharing impacts #drugdevelopment, ultimately leading to the delivery of safe and effective medications to patients. See it here: http://spr.ly/6047io0Jf

#QualitybyDesign (#QbD) is a systematic approach to #pharmaceuticaldevelopment and manufacturing that emphasizes designing quality into processes from the beginning rather than relying solely on end-product testing. During our recent webinar, Dr. Pouria Motevalian, director of #viralvector process development at Thermo Fisher Scientific, discussed our company’s #QbD approach, featuring a case study from our collaboration with NysnoBio. Learn more here: http://spr.ly/6043i9nCH

One of the highlights of #CPHIMilan 2024 is the opportunity to learn from industry experts in the #biotechnology and #pharmaceutical fields. Thermo Fisher Scientific is excited to participate in this knowledge exchange during two speaking sessions on Tuesday, October 8, 2024: 🔈 Panel discussion: Navigating industry shifts in CDMO-pharma relations - Time: 11:35 a.m. - 12:30 p.m. CEST - Location: Hall 5 Dr. Hrissi Samartzidou, Ph.D. will join this panel discussion on recent developments in the pharmaceutical industry, exploring how they’re driving significant transformation in the CDMO and CRO space. 🔈 Fireside chat: Navigating outsourcing partnerships for start-ups - Time: 13:15 p.m. - 13:30 p.m. CEST - Location: Hall 5 Kelly Howard will join this fireside chat on navigating outsourcing partnerships for start-ups, showcasing best practices for collaborating with external partners to accelerate growth and drive innovation. To learn more about these speaking sessions or schedule a meeting with our team, click here: http://spr.ly/6048imQkm

In our recent webinar, we explored the complex landscape of #activepharmaceuticalingredient (#API) commercial production, emphasizing its critical role in guaranteeing the quality, efficacy, and safety of pharmaceutical drugs. With a focus on Thermo Fisher Scientific's comprehensive approach, we showcased the indispensable guidance and solutions #CDMOs offer, encompassing #scalability, #sustainability, cost optimization, and manufacturing flexibility. Through case studies, we highlighted strategies for enhancing #commercialproduction processes, from leveraging cutting-edge technologies to ensuring #regulatorycompliance, demonstrating the impact of a strategic #CDMO partnership. Watch the on-demand webinar here: http://spr.ly/6041ilLmL

Exciting news from Thermo Fisher Scientific’s site in #Singapore: Our newly expanded operations are up and running with their first #techtransfer. Our local team was selected by a customer in #biopharma to support the development and manufacture of their #liquidvial product used to treat certain #autoimmune diseases and types of #cancer. This work will leverage the offerings of our site expansion, completed last year with assistance from the Singapore Economic Development Board (EDB). We are committed to serving as a reliable partner in the #Asia-Pacific region and globally. As our #biopharma customers work to deliver lifesaving #therapies for patients, they look to #CDMO partners to support them from molecule to market. Our team is there every step of the way — enabling our customers to make the world healthier, cleaner, and safer. To learn more about our #Singapore site, click here: http://spr.ly/6040iZq7C

For #biotech and #pharma companies seeking a competitive advantage, embracing a mindset focused on the #patientexperience is becoming a strategic imperative. Learn about four patient-centric trends shaping today’s #biopharma landscape, as detailed in the CPHI trend report, “The nexus between #patient and #bigpharma.” Additionally, explore how third-party vendors like integrated #CROs and #CDMOs can support #drugdevelopers in their efforts to prioritize patient centricity. Learn more here: http://spr.ly/604394ztD

Watch our new #voicesofpartnership video, featuring Angie West. Angie, a key player in Thermo Fisher Scientific’s #clinicaltrials division, was tasked with an urgent client request to support a global #clinicaltrial involving 60,000 patients across 35 countries each month. The challenge was intensified by a compressed timeline: A project of that scope would typically take eight weeks, but Angie’s team was only given four. Through coordination, Angie’s team transformed part of their facility into a training lab, ensuring trial operators were well prepared. Additionally, their project managers worked through weekends to maintain momentum. Thanks to these efforts, the team reduced their client’s #clinicaltrial cycle times by 55% and maintained that accelerated pace for 18 months. Learn more here: http://spr.ly/604994JrV